1011 — China NT Pharma Co Share News
0.000.00%
Last trade - 00:00- HK$436.54m
- HK$794.62m
- CNY24.16m
Brief: China Nt Pharma Group Says Unit Entered Licensing & Collaboration Agreement With Abcentra LLC
Brief: China Nt Pharma Says Finalized Major Terms Of Potential Acquisition
Brief: China Nt Pharma Group Company Says Trading In Shares Was Halted With Effect From Wednesday, 20 April
Brief: China Nt Pharma Group Seeks Trading Halt
Brief: China Nt Pharma Posts FY Loss Attributable Rmb542,000
Brief: China Nt Pharma Group Sees A Significant Increase In Revenue By About 25% For Six Months
Brief: China NT Pharma Group Posts FY Loss Attributable Of RMB357.6 Mln
Brief: China NT Pharma Group Co Says Unit Agreed To Sell The Mountains Ltd
Brief: China NT Pharma Says Quetiapine Fumarate Selected In Tender For National Centralized Pharmaceuticals Procurement
Brief: China Nt Pharma Sees Net Loss Of About Rmb85.0 Million For HY
Brief: China NT Pharma Group Company Sees A Loss For Six Months
Brief: China NT Pharma Says I Win Securities Ltd To Procure Placee(S) To Subscribe For Bonds Of Up To Hk$100 Million
Brief: China Nt Pharma Group Says Transferred Pfenex Rights To NT Pharma International
Brief: China Nt Pharma Group Company Seeks Trading Halt
Brief: China NT Pharma Group Company Posts FY Loss Attributable Of RMB 587.6 Mln
Operation For Certain Pharma Products
Brief: China NT Pharma Group Says Unit's Drug Shusi Got Approval In Consistency Evaluation
China NT Pharma surges as company says has drug that could treat new virus infections
Brief: China NT Pharma Group Updates On Potential Use Of "Ambroxol" For Coronavirus Treatment